Literature DB >> 3108034

PA-II, the L-fucose and D-mannose binding lectin of Pseudomonas aeruginosa stimulates human peripheral lymphocytes and murine splenocytes.

D Avichezer, N Gilboa-Garber.   

Abstract

Pseudomonas aeruginosa lectin PA-II agglutinates human peripheral lymphocytes and stimulates mitogenesis (predominantly in T cells), like the plant lectins PHA and Con A. Murine splenocytes are also agglutinated and stimulated by PA-II as by Con A. Sialidase treatment of the human and murine cells enhances their agglutination and augments the stimulation of human lymphocytes at low PA-II concentrations. The PA-II agglutinating and mitogenic effects are specifically inhibited by L-fucose. The bacterial source and the specificity of PA-II for L-fucose are both rare features among the hitherto described mitogenic lectins. However, since this lectin also binds mannose, a mannose-bearing receptor might be involved in its mitogenicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108034     DOI: 10.1016/0014-5793(87)80757-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Adoptive transfer of resistance to Pseudomonas aeruginosa infection by splenocytes and bone marrow cells from BALB/c mice immunized by Pseudomonas aeruginosa lectin preparations.

Authors:  D Avichezer; N Gilboa-Garber; M Mumcuoglu; S Slavin
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

2.  Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering β-catenin degradation.

Authors:  Catherine Cott; Roland Thuenauer; Alessia Landi; Katja Kühn; Samuel Juillot; Anne Imberty; Josef Madl; Thorsten Eierhoff; Winfried Römer
Journal:  Biochim Biophys Acta       Date:  2016-02-06

3.  Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of Pseudomonas aeruginosa.

Authors:  Siew Mun Liew; Ganeswrei Rajasekaram; Sd Ampalam Puthucheary; Kek Heng Chua
Journal:  PeerJ       Date:  2019-01-22       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.